[Federal Register Volume 59, Number 174 (Friday, September 9, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-22354]


[[Page Unknown]]

[Federal Register: September 9, 1994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

 

Advisory Committee Meeting; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is cancelling the joint 
meeting of the Dermatologic Drugs and Anti-Infective Drugs Advisory 
Committees scheduled for September 23, 1994, 1 p.m. to 5 p.m., to allow 
additional time for the agency to identify speakers concerning the 
potential for development of antibiotic resistance with over-the-
counter use of topical erythromycin in the treatment of acne. The 
meeting was announced in the Federal Register of August 22, 1994 (59 FR 
43126 at 43127). It is anticipated that the meeting will be rescheduled 
in a few months, to be announced at a later date in the Federal 
Register.

FOR FURTHER INFORMATION CONTACT: Ermona B. McGoodwin, Center for Drug 
Evaluation and Research (HFD-9), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-443-5455.

    Dated: September 2, 1994.
Linda A. Suydam,
Interim Deputy Commissioner for Operations.
[FR Doc. 94-22354 Filed 9-8-94; 8:45 am]
BILLING CODE 4160-01-F